Range Low Price High Price Comment
30 days $84.38 $96.99 Wednesday, 1st May 2024 BPMC stock ended at $94.86. This is 3.85% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 6.11% from a day low at $90.85 to a day high of $96.40.
90 days $72.25 $100.98
52 weeks $43.89 $100.98

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
Sep 26, 2023 $49.49 $50.85 $49.49 $49.93 320 773
Sep 25, 2023 $49.35 $49.99 $48.73 $49.33 389 911
Sep 22, 2023 $49.35 $50.19 $48.60 $49.52 333 890
Sep 21, 2023 $49.81 $50.33 $48.94 $49.37 476 702
Sep 20, 2023 $51.36 $51.84 $50.37 $50.57 329 101
Sep 19, 2023 $52.18 $52.18 $50.85 $51.33 315 813
Sep 18, 2023 $50.40 $52.90 $49.90 $52.19 596 324
Sep 15, 2023 $51.31 $51.53 $50.52 $50.62 752 468
Sep 14, 2023 $52.19 $52.84 $51.28 $51.37 299 145
Sep 13, 2023 $53.31 $53.41 $51.57 $51.93 339 152
Sep 12, 2023 $53.39 $54.33 $52.75 $52.81 341 958
Sep 11, 2023 $53.68 $54.98 $53.35 $53.55 535 853
Sep 08, 2023 $51.01 $54.89 $50.84 $53.39 613 460
Sep 07, 2023 $49.46 $50.96 $49.46 $50.65 416 276
Sep 06, 2023 $50.01 $50.17 $49.39 $50.05 272 991
Sep 05, 2023 $50.26 $50.94 $48.72 $49.69 530 090
Sep 01, 2023 $50.14 $50.86 $49.95 $50.64 534 837
Aug 31, 2023 $49.45 $50.48 $49.20 $49.86 503 095
Aug 30, 2023 $48.98 $49.74 $48.92 $49.30 305 492
Aug 29, 2023 $48.83 $49.56 $48.52 $48.85 269 028
Aug 28, 2023 $50.62 $51.04 $48.79 $49.03 275 252
Aug 25, 2023 $50.25 $50.79 $49.36 $50.57 422 787
Aug 24, 2023 $49.77 $50.00 $49.13 $49.65 238 059
Aug 23, 2023 $49.50 $50.41 $49.50 $49.76 293 572
Aug 22, 2023 $50.55 $51.36 $49.02 $49.34 960 410
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT